Abstract:Objective:To investigate the clinical characteristics of four McCune-Albright syndrome (MAS) patients associated with growth hormone(GH)-prolactin(PRL) pituitary adenoma, and explore more effective clinical treatment and management methods.Methods:The clinical data of four patients with MAS and GH-PRL pituitary adenoma diagnosed by Peking Union Medical College Hospital were retrospectively analyzed, including clinical manifestations, biochemical parameters, radiographic characteristics, as well as treatment and prognosis. Literature review was also conducted to analyze the efficacy of surgical operations and drug intervention.Results:Clinical characteristics: 3 females and 1 male, all of whom had onset before the age of 7 years. The types of fibrous dysplasia of bone were all polyosseous and involved craniofacial region. There were obvious gigantism/acromegaly manifestations in all cases, 3 cases had evident visual impairment and 1 case with optic chiasm compression. There was no spontaneous or triggered lactation in all 4 patients. Laboratory examination: GH and insulin-like growth factor-Ⅰ(IGF-Ⅰ) levels were significantly increased in 4 patients, GH levels were not inhibited by oral glucose tolerance test (OGTT), PRL levels were over 100 ng/ml, ALP levels were significantly increased in 4 patients, while serum calcium and phosphorus levels were remained normal. Imaging features: All pituitary adenomas in 4 patients were macroadenomas, with unilateral cavernous sinus enclosure in cases 2 and 3, and recurrence of macroadenoma with bilateral cavernous sinus enclosure in case 4 after the first operation. Four cases of skull CT showed multiple FD in craniofacial bone and skull base. Treatment and outcome: All 4 patients underwent pituitary adenoma resection and bisphosphonate therapy, and somatostatin analogues, dopamine receptor agonists and other treatments were selected according to the situation. Two patients with early diagnosis and initial treatment achieved partial remission after treatment, while the other two patients did not.Conclusions:Patients with MAS and GH-PRL pituitary adenoma had earlier onset age and were more likely to suffer from optic nerve damage. Early diagnosis and reasonable surgical treatment may help to improve biochemical indicators (GH, IGF-Ⅰ, and PRL, etc.) rapidly, and combined drug therapy (somatostatin analogues and dopamine receptor agonists) can better maintain or close to normal biochemical indicators, and ultimately improve the prognosis of patients.

Four patients with pituitary GH/PRL/TSH mixed adenoma: case studies and literature review

Clinical Features and Therapeutic Outcomes of GH/TSH Cosecreting Pituitary Adenomas: Experience of a Single Pituitary Center

Patients with true mixed growth hormone and prolactin-secreting pituitary adenoma: a case series of 12 patients

Clinical Characteristics and Management of Cosecreting Thyroid Stimulating Hormone or Prolactin Pituitary Growth Hormone Adenomas: A Case-Control Study

[Clinical Analysis of 13 Cases with Growth Hormone Deficiency Combined with Pituitary Stalk Interruption].

McCune-Albright syndrome associated with growth hormone-prolactin pituitary adenoma in 4 Chinese patients with literature review

Clinical characteristics and treatment of pituitary thyrotropin mixed secreting adenoma

The Diagnosis and Treatment of Growth Hormone Secreting Pituitary Adenomas: Analysis of 95 Cases

[Clinical case of plurihormonal pituitary adenoma (STH/ACTH/TSH/FSH/LH-secreting), diagnostic pitfalls]

Diagnosis and Treatment of Pediatric and Adolescent Pituitary Adenomas:A Report of 42 Cases

[A Clinical Analysis of Thyrotropin-Secreting Pituitary Adenomas in 20 Patients].

Pituitary adenoma: A clinicopathologic analysis of 180 cases

Pleiomorphism Plurihormonal Pit-1-positive Macroadenoma with Central Hyperthyroidism: a Rare Case Report and Literature Review

[Thyroid-stimulating hormone pituitary adenomas: clinical characteristics, diagnosis and treatment]

A retrospective review of 34 cases of pediatric pituitary adenoma

Analysis of Clinical Features of 428 Patients with Pituitary Tumor

[Hard Nut to Crack in Diagnosis of Pituitary Hyperplasia Secondary to Primary Hypothyroidism and Reasons of Misdiagnosis].

Pathogenesis, clinical features, and treatment of plurihormonal pituitary adenoma

Surgical Results and Predictors of Initial and Delayed Remission for Growth Hormone-Secreting Pituitary Adenomas Using the 2010 Consensus Criteria in 162 Patients from a Single Center

Immunopathological Study of Plurihormonal Pituitary Adenomas

Surgical treatment of giant pituitary adenomas via transsphenoidal approach